Earnings ·
Baxter International Inc. reported second-quarter 2026 results with worldwide sales of $2.96 billion, a 5% increase on…
BAXBaxter International Inc
Baxter International Inc. reported second-quarter 2026 results with worldwide sales of $2.96 billion, a 5% increase on both a reported and organic basis. U.S. GAAP diluted earnings per share were $0.26, while adjusted diluted EPS was $0.56. The company raised its full-year 2026 financial outlook, projecting reported sales growth of 3% to 4%, organic sales growth of 2% to 3%, and adjusted EPS between $1.95 and $2.15. Additionally, the Board declared a quarterly cash dividend of $0.01 per share, payable on October 1, 2026, to stockholders of record as of August 28, 2026. Baxter International Inc. is a global medical technology company providing essential solutions in hospital and physician office settings.